Medikit Co.,Ltd. (TYO:7749)

Japan flag Japan · Delayed Price · Currency is JPY
2,995.00
-15.00 (-0.50%)
Mar 10, 2026, 9:00 AM JST
16.27%
Market Cap 43.81B
Revenue (ttm) 23.68B
Net Income (ttm) 3.09B
Shares Out 14.63M
EPS (ttm) 211.89
PE Ratio 14.13
Forward PE n/a
Dividend 100.00 (3.32%)
Ex-Dividend Date Mar 30, 2026
Volume 5,400
Average Volume 3,440
Open 2,999.00
Previous Close 3,010.00
Day's Range 2,995.00 - 2,999.00
52-Week Range 2,362.00 - 3,095.00
Beta 0.11
RSI 50.75
Earnings Date Feb 12, 2026

About Medikit

Medikit Co.,Ltd., together with its subsidiaries, develops, manufactures, sells, and exports medical devices related to blood vessels and blood in Japan and internationally. The company offers IV catheters, such as Supercath 5 and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath sheath introducers and Mongoose angiography catheters. It also provides indwelling needles for artificial dialysis; and needles for blood transfusions and infusions.... [Read more]

Sector Healthcare
Founded 1973
Employees 989
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7749
Full Company Profile

Financial Performance

In fiscal year 2025, Medikit's revenue was 22.55 billion, an increase of 3.22% compared to the previous year's 21.85 billion. Earnings were 3.01 billion, a decrease of -1.82%.

Financial Statements

News

There is no news available yet.